Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses (Q64380569)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses |
article |
Statements
Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses (English)
0 references
1 September 2000
0 references
87
0 references
5
0 references
665-72
0 references